Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DIA names worldwide executive director

This article was originally published in SRA

Executive Summary

The Drug Information Association has named Paul Pomerantz as its new worldwide executive director, effective 1 December 2009. Mr Pomerantz, who is currently executive vice president of the American Society of Plastic Surgeons, will replace William Brassington, who has been acting executive director since July 2008; Mr Brassington will resume his role as the DIA’s worldwide director of finance.

You may also be interested in...



Pharma Guidelines, ending 1 July 2011

Recently updated and newly issued documents

EuropaBio appoints new chairman

EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.

Medtech Guidelines, ending 24 June 2011

Recently updated and newly issued documents

Latest Headlines
See All
UsernamePublicRestriction

Register

PS114590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel